Cargando…

Exome Analysis Reveals Differentially Mutated Gene Signatures of Stage, Grade and Subtype in Breast Cancers

Breast cancers exhibit highly heterogeneous molecular profiles. Although gene expression profiles have been used to predict the risks and prognostic outcomes of breast cancers, the high variability of gene expression limits its clinical application. In contrast, genetic mutation profiles would be mo...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, You, Wang, Xiaosheng, Vural, Suleyman, Mishra, Nitish K., Cowan, Kenneth H., Guda, Chittibabu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372331/
https://www.ncbi.nlm.nih.gov/pubmed/25803781
http://dx.doi.org/10.1371/journal.pone.0119383
_version_ 1782363162774863872
author Li, You
Wang, Xiaosheng
Vural, Suleyman
Mishra, Nitish K.
Cowan, Kenneth H.
Guda, Chittibabu
author_facet Li, You
Wang, Xiaosheng
Vural, Suleyman
Mishra, Nitish K.
Cowan, Kenneth H.
Guda, Chittibabu
author_sort Li, You
collection PubMed
description Breast cancers exhibit highly heterogeneous molecular profiles. Although gene expression profiles have been used to predict the risks and prognostic outcomes of breast cancers, the high variability of gene expression limits its clinical application. In contrast, genetic mutation profiles would be more advantageous than gene expression profiles because genetic mutations can be stably detected and the mutational heterogeneity widely exists in breast cancer genomes. We analyzed 98 breast cancer whole exome samples that were sorted into three subtypes, two grades and two stages. The sum deleterious effect of all mutations in each gene was scored to identify differentially mutated genes (DMGs) for this case-control study. DMGs were corroborated using extensive published knowledge. Functional consequences of deleterious SNVs on protein structure and function were also investigated. Genes such as ERBB2, ESP8, PPP2R4, KIAA0922, SP4, CENPJ, PRCP and SELP that have been experimentally or clinically verified to be tightly associated with breast cancer prognosis are among the DMGs identified in this study. We also identified some genes such as ARL6IP5, RAET1E, and ANO7 that could be crucial for breast cancer development and prognosis. Further, SNVs such as rs1058808, rs2480452, rs61751507, rs79167802, rs11540666, and rs2229437 that potentially influence protein functions are observed at significantly different frequencies in different comparison groups. Protein structure modeling revealed that many non-synonymous SNVs have a deleterious effect on protein stability, structure and function. Mutational profiling at gene- and SNV-level revealed differential patterns within each breast cancer comparison group, and the gene signatures correlate with expected prognostic characteristics of breast cancer classes. Some of the genes and SNVs identified in this study show high promise and are worthy of further investigation by experimental studies.
format Online
Article
Text
id pubmed-4372331
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-43723312015-04-04 Exome Analysis Reveals Differentially Mutated Gene Signatures of Stage, Grade and Subtype in Breast Cancers Li, You Wang, Xiaosheng Vural, Suleyman Mishra, Nitish K. Cowan, Kenneth H. Guda, Chittibabu PLoS One Research Article Breast cancers exhibit highly heterogeneous molecular profiles. Although gene expression profiles have been used to predict the risks and prognostic outcomes of breast cancers, the high variability of gene expression limits its clinical application. In contrast, genetic mutation profiles would be more advantageous than gene expression profiles because genetic mutations can be stably detected and the mutational heterogeneity widely exists in breast cancer genomes. We analyzed 98 breast cancer whole exome samples that were sorted into three subtypes, two grades and two stages. The sum deleterious effect of all mutations in each gene was scored to identify differentially mutated genes (DMGs) for this case-control study. DMGs were corroborated using extensive published knowledge. Functional consequences of deleterious SNVs on protein structure and function were also investigated. Genes such as ERBB2, ESP8, PPP2R4, KIAA0922, SP4, CENPJ, PRCP and SELP that have been experimentally or clinically verified to be tightly associated with breast cancer prognosis are among the DMGs identified in this study. We also identified some genes such as ARL6IP5, RAET1E, and ANO7 that could be crucial for breast cancer development and prognosis. Further, SNVs such as rs1058808, rs2480452, rs61751507, rs79167802, rs11540666, and rs2229437 that potentially influence protein functions are observed at significantly different frequencies in different comparison groups. Protein structure modeling revealed that many non-synonymous SNVs have a deleterious effect on protein stability, structure and function. Mutational profiling at gene- and SNV-level revealed differential patterns within each breast cancer comparison group, and the gene signatures correlate with expected prognostic characteristics of breast cancer classes. Some of the genes and SNVs identified in this study show high promise and are worthy of further investigation by experimental studies. Public Library of Science 2015-03-24 /pmc/articles/PMC4372331/ /pubmed/25803781 http://dx.doi.org/10.1371/journal.pone.0119383 Text en © 2015 Li et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Li, You
Wang, Xiaosheng
Vural, Suleyman
Mishra, Nitish K.
Cowan, Kenneth H.
Guda, Chittibabu
Exome Analysis Reveals Differentially Mutated Gene Signatures of Stage, Grade and Subtype in Breast Cancers
title Exome Analysis Reveals Differentially Mutated Gene Signatures of Stage, Grade and Subtype in Breast Cancers
title_full Exome Analysis Reveals Differentially Mutated Gene Signatures of Stage, Grade and Subtype in Breast Cancers
title_fullStr Exome Analysis Reveals Differentially Mutated Gene Signatures of Stage, Grade and Subtype in Breast Cancers
title_full_unstemmed Exome Analysis Reveals Differentially Mutated Gene Signatures of Stage, Grade and Subtype in Breast Cancers
title_short Exome Analysis Reveals Differentially Mutated Gene Signatures of Stage, Grade and Subtype in Breast Cancers
title_sort exome analysis reveals differentially mutated gene signatures of stage, grade and subtype in breast cancers
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4372331/
https://www.ncbi.nlm.nih.gov/pubmed/25803781
http://dx.doi.org/10.1371/journal.pone.0119383
work_keys_str_mv AT liyou exomeanalysisrevealsdifferentiallymutatedgenesignaturesofstagegradeandsubtypeinbreastcancers
AT wangxiaosheng exomeanalysisrevealsdifferentiallymutatedgenesignaturesofstagegradeandsubtypeinbreastcancers
AT vuralsuleyman exomeanalysisrevealsdifferentiallymutatedgenesignaturesofstagegradeandsubtypeinbreastcancers
AT mishranitishk exomeanalysisrevealsdifferentiallymutatedgenesignaturesofstagegradeandsubtypeinbreastcancers
AT cowankennethh exomeanalysisrevealsdifferentiallymutatedgenesignaturesofstagegradeandsubtypeinbreastcancers
AT gudachittibabu exomeanalysisrevealsdifferentiallymutatedgenesignaturesofstagegradeandsubtypeinbreastcancers